Myriad Genetics Inc (MYGN)
17.60
-0.24
(-1.32%)
USD |
NASDAQ |
Nov 05, 16:00
17.50
-0.10
(-0.54%)
After-Hours: 20:00
Myriad Genetics Debt to Equity Ratio: 0.0524 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.0524 |
| March 31, 2024 | 0.0509 |
| December 31, 2023 | 0.0492 |
| September 30, 2023 | 0.0563 |
| June 30, 2023 | 0.0522 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.1153 |
| March 31, 2021 | 0.176 |
| September 30, 2020 | 0.247 |
| June 30, 2020 | 0.2444 |
| March 31, 2020 | 0.2328 |
| December 31, 2019 | 0.209 |
| September 30, 2019 | 0.2094 |
| June 30, 2019 | 0.2144 |
| March 31, 2019 | 0.2435 |
| December 31, 2018 | 0.2568 |
| September 30, 2018 | 0.2341 |
| June 30, 2018 | 0.0096 |
| March 31, 2018 | 0.0731 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.0473 |
| September 30, 2017 | 0.0852 |
| June 30, 2017 | 0.129 |
| March 31, 2017 | 0.2233 |
| December 31, 2016 | 0.2783 |
| September 30, 2016 | 0.2708 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2021
0.247
Maximum
Sep 2020
0.0825
Average
0.0515
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5254 |
| Abbott Laboratories | 0.3764 |
| Personalis Inc | 0.0203 |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.085B |
| Total Liabilities (Quarterly) | 344.60M |
| Shareholders Equity (Quarterly) | 740.50M |
| Current Ratio | 1.958 |
| Net Debt Paydown Yield | -0.35% |